Is a complete BRNS research report available?

No complete published report is available for Barinthus Biotherapeutics plc (BRNS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Barinthus Biotherapeutics plc (BRNS)

NASDAQ: BRNS · USD

$0.56

-0.02 (-2.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BRNS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	22.8M
Net income (ttm)	-52.3M
EPS (ttm)	-$1.29
Shares out	40.8M
Volume	26,382.663
Beta	-0.40
Price target	$5.50	+887.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -52.3M
EPS (ttm): -$1.29
Market cap: 22.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BRNS indicators

Market & fundamental data

Available fields

185

Groups with data

Currency

USD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001828185
Company name	Barinthus Biotherapeutics plc
Country	United States
Country code	US
Cusip	91864C107
Employees	14
Employees Change	-91%
Employees Change Percent	-86.67
Enterprise value	$-32.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-04-30
Isin	US91864C1071
Last refreshed	2026-07-31
Market cap	$22.8M
Market cap category	Nano-Cap
Price	$0.56
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	BRNS
Website	https://www.barinthusbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-229.91%
FCF yield	-160.31%
P/B ratio	0.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-336,000
Net Income	$-52.3M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Profit Per Employee	$-3.7M
ROA	-23.21
Roa5y	-16.05
ROCE	-69.91
ROE	-57.49
Roe5y	-35.32
ROIC	-26.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-63.62%
Cagr3y	-37.66%
Cagr5y	-48.09%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$92.1M
Cash	$65.9M
Current Assets	$72.7M
Current Liabilities	$12M
Debt	$11M
Debt Equity	$0.17
Equity	$66.5M
Interest Coverage	-1,098.6
Liabilities	$25.7M
Long Term Assets	$19.5M
Long Term Liabilities	$13.7M
Net Cash	$54.9M
Net Cash By Market Cap	$241
Net Cash Growth	-37.1%
Net Debt Equity	$-0.83
Tangible Book Value	$52.7M
Tangible Book Value Per Share	$1.29
WACC	1.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.05
Net Working Capital	$-3.2M
Quick ratio	5.6
Working Capital	$60.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.4%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-63.59%
200-day SMA	0.73
3Y total return	-75.78%
50-day SMA	0.66
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.23%
All Time High	17.99
All Time High Change	-96.9%
All Time High Date	2021-05-17
All Time Low	0.51
All Time Low Change	8.79%
All Time Low Date	2026-03-24
ATR	0.05
Beta	-0.4
Beta1y	1.57
Beta2y	1.85
Ch YTD	-20.44
High	0.62
High52	1.83
High52 Date	2025-10-07
High52ch	-69.56%
Low	0.54
Low52	0.51
Low52 Date	2026-03-24
Low52ch	8.79%
Ma50ch	-14.99%
Premarket Change Percent	7.2
Premarket Price	$0.62
Premarket Volume	439
Price vs 200-day SMA	-23.8%
RSI	37.91
RSI Monthly	34.99
RSI Weekly	38.68
Sharpe ratio	-0.91x
Sortino ratio	-1.2
Total Return	-2.4%
Tr YTD	-20.44
Tr1m	-15.68%
Tr1w	-7.18%
Tr3m	-7.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.3
Operating Income	$-43.5M
Price target	$5.5
Price Target Change	$887

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,257,502%
Float Percent	66.73%
Shares Insiders	11.74%
Shares Institutions	31.12%
Shares Out	40,848,893
Shares Qo Q	0.03%
Shares Yo Y	2.4%
Short Ratio	0.58
Short Shares	0.12

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-37M
Adjusted OCF	-36,999,000
Average Volume	43,116.95x
Bv Per Share	1.63
CAPEX	$-32,000
Ch1m	-15.68
Ch1w	-7.18
Ch1y	-63.59
Ch3m	-7.15
Ch3y	-75.78
Ch5y	-96.23
Ch6m	-22.79
Change	-2.91%
Change From Open	3.15
Close	0.57
Days Gap	-5.87
Depreciation Amortization	1,867,000
Dollar Volume	14,695.1
Earnings Date	2026-08-10
Earnings Time	bmo
EBIT	$-56M
EBITDA	$-51.4M
EPS	$-1.29
F Score	1
FCF	$-36.5M
FCF EV Yield	113.64x
FCF Per Share	$-0.89
Fiscal Year End	December
Founded	2,016
Income Tax	$-169,000
Investing CF	476,000
Ipr	-96.72
Iprfo	-95.91
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-13
Ma150	0.65
Ma150ch	-14.49%
Ma20	0.61
Ma20ch	-8.85%
Net CF	-33,390,000
Next Earnings Date	2026-08-10
Open	0.54
Optionable	No
Position In Range	22.67
Post Close	0.56
Postmarket Change Percent	0.14
Postmarket Price	$0.56
Ppne	4,899,000
Pre Close	0.57
Price Date	2026-07-30
Ptbv Ratio	0.43
Relative Volume	0.61x
Share Based Comp	556,000
Tr6m	-22.79%
Us State	Maryland
Volume	26,382.7

Barinthus Biotherapeutics plc (BRNS)

Coverage state: Market snapshot only — no published research

Generate the first BRNS analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BRNS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BRNS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BRNS

Frequently asked questions